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sensitive strain P3343110. When test-
ed by long PCR, all 20 S. Java isolates
produced a 10,041-bp fragment iden-
tical to that produced by P3170700. 
PCR was used to determine
whether the pentaresistant phenotype
was due to the presence of the
Salmonella genomic island 1 (SGI1)
as previously described (5). All 20
strains produced amplicons with
primers U7-L12 and LJ-R1 for the left
junction and primers 104-RJ and 104-
D for the right junction. These results
indicate that the SGI1 in the strains of
S. Java was located in the same chro-
mosomal location as previously
described for DT 104 ACSSpSuT but
lacks the retronphage found to date
only in DT104 strains (6).
These findings demonstrated that
the ACSSpSuT resistance gene cluster
in S. Java isolated from patients in the
United Kingdom from 2000 to March
2003 appeared to be chromosomally
located and was almost indistinguish-
able from that found in the epidemic
clone of DT104 ACSSpSuT. This
resistance gene cluster has also been
identified in strains of S. Agona from
poultry in Belgium (6), in a strain of
S. Paratyphi B from tropical fish in
Singapore (7), and a variant cluster in
a strain of S. Albany from fish food
from Thailand (8). It also appears to
be present in isolates of S. Paratyphi B
of R-type ACSSpSuT from cases of
human infection in France in 2003 (F.
Xavier-Weill, pers. comm.). The
strains of S. Paratyphi B from
Singapore and France were not tested
additionally to identify the Java vari-
ant. 
The strains of S. Java with chro-
mosomally integrated ACSSpSuT
resistance identified in the United
Kingdom are not those associated
with poultry in Germany (9) or the
Netherlands (10), which have also
caused infections in humans in the
United Kingdom (1). The latter strains
have different phage types, resistant
spectrums, pulsed-field profiles, and
they possess plasmid-mediated drug-
resistance. However, several S. Java
infections in the United Kingdom
have been associated with tropical
fish tanks (L.R. Ward, unpub. data),
although the strain has not been isolat-
ed from this medium. A substantive
increase in multiresistant S. Java has
also been reported in Australia (D.
Lightfoot, pers. comm.). The antibi-
ogram of these isolates are indistin-
guishable from the isolates of R-type
ACSSpSuT made in the United
Kingdom. 
These results suggest either a com-
mon origin of the ACSSpSuT-resist-
ance gene cluster in epidemic multire-
sistant DT104 and multiresistant S.
Java or the horizontal transfer of the
cluster from DT104 to other
Salmonella serovars with a worldwide
distribution. In either event, the
increasing occurrence of the DT104
resistance gene cluster in potentially
epidemic serovars other than S.
Typhimurium DT104 is concerning. 
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1990s Vibrio
cholerae Epidemic,
Brazil
To the Editor: We read with inter-
est the letter by Sarkar et al. on new
Vibrio cholerae phages (1). The
description of new V. cholerae phages
is a welcome tool for epidemiologic
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studies of this species. Our main con-
cern about their work is the inaccurate
picture that is presented of the cholera
epidemic in Brazil. Some of the state-
ments made in the final paragraphs
are in disagreement with the official
epidemiologic records and the charac-
teristics of the Vibrio  bacteria that
occurred in Brazil during the 1990s
epidemic (2).
In 1991, the seventh cholera pan-
demic reached South America by the
Pacific coast, spreading to Brazil in
the same year (3). In Brazil, the first
cholera cases were reported in the
Amazon region bordering Peru; with-
in a few months a large number of
cholera cases were recorded in states
facing the Atlantic Ocean in the north-
eastern region (2). According to the
official figures of the Brazilian
Ministry of Health (2), 168,598 cases
of cholera caused by a V. cholerae O1
El Tor strain occurred in Brazil from
1991 to 2001. Of these, 155,363
(92.1%) occurred in the northeastern
area of the country, with 2,037 deaths.
From 2001 to 2003, the number of
confirmed cases was 4,756, 734, and
7, respectively.
Sarkar et al. (1) indicate that
60,000 cases occurred from 1991 to
2001 in Rio de Janeiro, a city local-
ized in the southeastern region; the
official records report only 349 cases.
The statement that “since 1993, no
cholera cases caused by O1 have been
reported” is also perplexing. From
1994 to 2001, the official records
report 68,583 cases of cholera in
Brazil (51,324 of these in 1994, the
second major year of cholera inci-
dence). Are the authors suggesting
that this number of cases was caused
by non-O1 V. cholerae? The official
records state that the cholera epidem-
ic in Brazil was caused by an El Tor
O1 strain (4,5). 
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Fluoroquinolone-
resistant
Salmonella
Paratyphi A 
To the Editor: Fluoroquinolones
have been the drug of choice for treat-
ing typhoid and paratyphoid fever
since the beginning of the 1990s.
Multidrug-resistant strains began to
prevail in disease-endemic areas, and
former first-line antimicrobial drugs,
such as chloramphenicol, were some-
times ineffective (1). In recent years,
however, strains with decreased sus-
ceptibility to quinolones have
emerged, and clinical treatment fail-
ure is a serious concern (2–5).
An 87-year-old woman was
referred from a local clinic to
Yokohama Municipal Citizen’s
Hospital in July 2002 because
Salmonella enterica serovar Paratyphi
A was detected in her urine. She had
no subjective symptoms such as pain
on urination or urinary urgency, and
her temperature was normal. She had
never had paratyphoid fever, and she
had not traveled abroad. No other per-
son in the community had paraty-
phoid. Before being admitted to the
hospital, she had experienced frequent
episodes of urinary tract infection and
had been empirically treated each
time with oral antimicrobial drugs,
including ciprofloxacin. She had been
given a dose of 600 mg/day for 7
days, 25 times in the last 4 years.
The patient did not display any
abnormal findings on physical exami-
nation. S. Paratyphi A was not detect-
ed in the urine but was confirmed in
the stool; therefore, the previous
report of bacteriuria could have been
due to contamination of a urine sam-
ple with feces. An ultrasound showed
a polyp and multiple stones in her
gallbladder. A carrier state was sus-
pected. Bile was obtained by duode-
nal aspiration and was positive for S.
Paratyphi A. The patient was consid-
ered to be an asymptomatic cholecys-
tic carrier of S. Paratyphi A.
On disk diffusion susceptibility
testing, the isolate was resistant to
nalidixic acid (NA) and to ofloxacin.
The MIC of ofloxacin was as high as
256 µg/mL, and the MIC of
ciprofloxacin was128 µg/mL (Table).
An open cholecystectomy was per-
formed for treatment of the polyp, the
stones, and the highly quinolone-
resistant bacteria. Aroutine periopera-
tive intravenous antimicrobial agent,
cefmetazole, was administered as sur-
gical prophylaxis. The polyp was
malignant, and the operation was
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